A 45-year-old woman presented to the emergency department of a tertiary referral hospital after taking an overdose of verapamil, doxepin, quetiapine, diazepam, temazepam, and clonazepam. She rapidly developed shock refractory to pharmacological support and was placed on percutaneous venoarterial extracorporeal membrane oxygenation (ECMO). She had a severe metabolic acidosis from a combination of shock and drug intoxication that improved with continuous venovenous haemodialysis. Forty-eight hours after presentation, while still on ECMO, the patient had complete cardiac standstill for three and a half hours, attributable to slow-release verapamil, that resolved after the commencement of plasmapheresis. The role of plasmapheresis in verapamil overdose requires further study.
The use of extracorporeal circuitry in the management of certain drug overdoses is usually confined to haemodialysis or haemoperfusion to enhance drug elimination, although there are reports of patients requiring treatment with two forms of extracorporeal support, such as extracorporeal membrane oxygenation (ECMO) and haemofiltration 1 . We report the case of a patient with a polypharmacy overdose who was successfully treated with three different forms of extracorporeal life support.
CASE HISTORY
A 45-year-old woman was brought to the emergency department fifty minutes after being found unconscious in a park surrounded by empty packets of medications. On arrival (Day 1: 1930h) she had a heart rate of 92 beats per minute (bpm), a mean arterial blood pressure (MAP) of 73 mmHg and a Glasgow Coma Score of 6 out of 15. Her pupils were small but reactive. Intravenous access was established, her airway was secured with an endotracheal tube, activated charcoal (50 g) was administered down a nasogastric tube and an arterial line was placed. An arterial blood gas taken after endotracheal intubation showed a metabolic acidosis with a pH of 7.28, a base excess of -7 mmol/l and an anion gap of 16 mEq/l. A baseline electrocardiograph (ECG) showed no abnormalities. She was given intravenous crystalloid and a Foley catheter was inserted. It was established that the patient had taken 7.2 g of slow-release verapamil, 1.6 g of doxepin, 10 g of quetiapine, 2 g of diazepam, 200 mg of temazepam and 100 mg of clonazepam.
Soon after arrival in the emergency department the patient became profoundly hypotensive (MAP 37 mmHg). A central venous catheter was placed and adrenaline and noradrenaline infusions were commenced. A repeat ECG showed widespread ST depression consistent with extensive subendocardial ischaemia. A transthoracic echocardiogram showed a hyperdynamic left ventricle with no segmental wall motion abnormalities or valve dysfunction. She deteriorated further and despite high-dose adrenaline and noradrenaline infusions (80 and 40 µg/min respectively), bolus doses of glucagon (two doses of 2 mg), adrenaline (one bolus of 0.5 mg and one of 1 mg), calcium chloride (1.5 g), and sodium bicarbonate (100 mmol), her MAP remained at 50 mmHg. The decision was made to institute ECMO in the emergency department. The patient's right femoral artery and vein were cannulated percutaneously with 19 Fr and 23 Fr Biomedicus Carmeda-coated cannulae (Medtronic, Minnesota, U.S.A.) respectively, with an additional 8.5 Fr backflow cannula (Super Arrow-Flex, Arrow Int, Reading, PA, U.S.A.) to perfuse the right leg. A 5000 U bolus of intravenous heparin was given and followed by an infusion at 300 U/h. The ECMO circuit consisted of a Rotaflow RF32 pump, a Quadrox HMOD 1010 oxygenator, and a Bioline-coated circuit (all manufactured by Jostra AG, Hirrlingen, Germany). Flows of 5 l/min were successfully established (Day 2: 0025 h) and the inotropes were tapered (to 4 µg/min of adrenaline and 20 µg/min of noradrenaline). The changes seen on ECG resolved. The patient was transferred to the intensive care unit (ICU).
On arrival in ICU the patient was noted to have an arterial pH of 7.12 and a base excess of -14 mmol/l. A 13.5 Fr left femoral vein catheter (Niagara vascath, Bard Access Systems, Utah, U.S.A.) was inserted and continuous venovenous haemodialysis (CVVHD) was initiated. The patient's blood sugar level was 20.3 mmol/l. Sodium bicarbonate (50 mmol/h), calcium chloride (1.5 g/h), insulin (10 U/h), and potassium chloride (20 mmol/h) infusions were given. An additional dose of activated charcoal was administered. A volume-cycled ventilator was used with a FiO 2 0.4, tidal volumes of 8 ml/kg, a rate of 5 breaths/ min and a positive end-expiratory pressure of 5 cm H 2 O. Once CVVHD was established, her adrenaline was ceased and she stabilized on moderate doses of noradrenaline (15 µg/min). She remained haemodynamically stable throughout the rest of the second day of hospital admission and her calcium and bicarbonate infusions were stopped. Her serum troponin I peaked at 8.3 µg/l.
By the third day the patient, who had remained unsedated up to this point, opened her eyes spontaneously for the first time (Day 3: 0600). Her acidosis had resolved and CVVHD was ceased. However, several hours later she became hypotensive again, requiring reinstitution of adrenaline (up to 8 µg/min) and escalation of noradrenaline (up to 33 µg/min). She was sedated with morphine and midazolam. A repeat transthoracic echocardiogram showed a global reduction in systolic function with a left ventricular ejection fraction of 30%. Her inotrope requirements fluctuated considerably throughout the day. Early in the evening she became bradycardic (50 bpm) for the first time and then suddenly went into asystole (Day 3: 1930 h). Atropine (total 2.4 mg) boluses were administered, high-dose infusions of adrenaline and dobutamine were tried and transcutaneous pacing was attempted, all with no effect. Adequate peripheral perfusion was maintained with ECMO and her MAP remained at 70 mmHg with the addition of 1 U/h of vasopressin. The heparin infusion was increased to 1000 U/h to decrease the risk of thrombus formation during cardiac standstill. Her insulin regimen was modified to a glucose-insulin-potassium infusion (GIK; 1 litre 10% dextrose with 20 mmol potassium chloride and 50 U Actrapid) at 60 ml/h. Bowel irrigation with polyethylene glycol was attempted but soon abandoned as the patient developed a distended abdomen. Plasmapheresis was commenced (Day 3: 2215 h) (Prisma system, Hospal, Lyon, France) using the CVVHD access catheter. The patient underwent a 3 litre exchange with 5% human albumin and fresh frozen plasma. Fifty minutes following commencement of plasmapheresis she had return of spontaneous circulation with a junctional rhythm at 50 bpm and a pulse pressure of 35 mmHg (Day 3: 2305). By the end of the exchange she was in sinus rhythm with first-degree heart block at a rate of 80 bpm.
Thereafter the patient made considerable improvement. By the fifth day, the glucose-insulin-potassium infusion and all inotropes had been discontinued. On the sixth day she was weaned off ECMO and decannulated in the operating theatre. She was extubated on the seventh day and was transferred out of the Intensive Care Unit the following day. One week later she entered a psychiatric facility where she is currently being treated for depression. She did not suffer any long-term complications as a result of the overdose.
DISCUSSION
We report the case of a patient with a polypharmacy overdose who rapidly developed severe shock and was treated with multimodality extracorporeal life support. She received ECMO to maintain organ perfusion, CVVHD to correct a metabolic acidosis, and apparently responded to plasmapheresis when she later developed complete cardiac standstill. She made a full recovery. The case highlights certain management issues that may be relevant to a wide variety of life-threatening drug overdoses, principally the importance of mechanical forms of support when pharmacological therapies fail.
Distinguishing which agent is responsible for cardiovascular toxicity in polypharmacy overdose can be important in guiding therapy. Our patient had taken three agents that can have significant cardiovascular adverse effects: verapamil, doxepin, and quetiapine. Verapamil is a phenylalkylamine that binds to the α 1C subunit of L-type calcium channels, reducing the influx of extracellular calcium 2 . It is a negative inotrope and chronotrope that causes hypotension in overdose by impeding cardiac contractility and causing peripheral vasodilation. Doxepin causes cardiovascular toxicity by a host of mechanisms including inhibition of cardiac fast sodium channels and α 1 -adrenergic receptor antagonism 3 . Quetiapine, a dibenzothiazepine antipsychotic, works primarily by inhibiting serotonin and dopamine receptors. It uncommonly causes hypotension. In a recent case series of quetiapine overdoses, only one patient (who had taken 24 g) out of eighteen patients developed hypotension 4 . Treatment of these overdoses consists of preventing absorption from the gastrointestinal tract with activated charcoal and the administration of intravenous calcium or sodium bicarbonate, for calcium channel blocker and TCA poisoning respectively 2,3 . In addition, insulin-glucose regimens have been used successfully to improve circulatory stability in patients with calcium channel blocker overdose 5, 6 . Otherwise, the management of patients with these overdoses is essentially supportive. Inotropes may be required in severe cases. If these are ineffective, extracorporeal life support can be employed to maintain organ perfusion. ECMO has been successfully used to support patients with verapamil 7 , diltiazem 8 and desipramine 9 overdoses.
It is unclear which drug was primarily responsible for the initial hypotension and shock. She had preserved systolic function and no bradycardia, features not typical of significant verapamil intoxication, and lacked the anticholinergic signs and QRS prolongation that might be expected in a severe doxepin overdose. It is likely that both of these drugs, plus the quetiapine, synergistically induced shock by different mechanisms, affecting peripheral vasomotor tone but initially preserving pulse rate and systolic function. In addition, the patient had electrocardiographic and serological evidence of cardiac ischaemia, caused by either severe hypotension or high-dose catecholamines. Regardless of the mechanism of hypotension, it was refractory to pharmacological therapy and required mechanical support. ECMO was successfully instituted with immediate reduction in her inotrope requirements and resolution of her ECG changes.
Although the exact mechanism of the patient's hypotension in the emergency department is debatable, it seems most likely that her haemodynamic instability on the third day, culminating in cardiac standstill for over three and a half hours, was due to slow-release verapamil. No other clinically apparent events such as hyperkalaemia or hypoxia precipitated the arrest. Slow-release verapamil preparations are known to have a marked delay in the onset of effects, although to our knowledge this is the first report of a patient having an asystolic arrest over 48 hours following overdose. The patient again failed to respond to conventional therapy, including pacing and chronotropes, necessitating an attempt at secondary detoxification.
Extracorporeal elimination of verapamil is not generally recommended as standard therapy for many reasons. In particular, it exhibits too much protein binding to be adequately cleared by haemodialysis or haemoperfusion and theoretically has too high a volume of distribution (3.1-4.9 l/kg) to be removed by plasma exchange, which is generally only effective at clearing drugs with a low volume of distribution (<0.2 l/kg of body weight) 10 . Nonetheless, there have been successful reports of plasmapheresis in verapamil overdose 11, 12 . The apparent effects in our patient were dramatic, with restoration of cardiac output fifty minutes after initiation of plasma exchange. Ideally, correlation of this observation by measuring serum verapamil before and after plasma exchange would have provided more objective evidence of the effects of plasmapheresis on verapamil levels, but unfortunately this was not available to us at the time. The role of plasmapheresis in verapamil overdose deserves further study.
This case also highlights the importance of thorough gastrointestinal decontamination. Whole bowel irrigation with polyethylene glycol has been recommended in verapamil poisoning 13 , but the evidence to support this is limited. With the benefit of hindsight, it is apparent that our patient did not receive adequate primary detoxification. A more aggressive attempt to prevent absorption in the first few hours after presentation might have prevented the haemodynamic instability and eventual cardiac arrest on the third day.
